MedTrace Logo

Interference Screw Mectascrew-C Postmarket Study

NCT05791656 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2024-05-01

No results posted yet for this study

Summary

An observational prospective study with the aim to analyze the presence at 6 months of a specific composite IS (Medacta Mectascrew C) in the reconstructive treatment of ruptured ACL or PCL by means of an autograft or allograft.

Conditions

  • Anterior Cruciate Ligament Injuries
  • Posterior Cruciate Ligament Tear

Interventions

DEVICE

Mectascrew-C

reconstruction of ACL or PCL rupture

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Principal Investigators

  • Christian Candrian, Prof Med · EOC , Service of Orthopaedics and Traumatology, Lugano (Switzerland)

Eligibility

Min Age
16 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-22
Primary Completion
2025-03-31
Completion
2025-03-31
FDA Device
Yes

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05791656 on ClinicalTrials.gov